arzu didem yalcin.md internal medicine, allergy and clinical immunology

18
POLLEN AERO ALLERGENS AND THE CLIMATE IN MEDITERRANEAN REGION OF TURKEY AND ALLERGEN SENSITIVITY IN ALLERGIC RHINOCONJUNCTIVITIS AND ALLERGIC ASTHMA PATIENTS Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

Upload: una

Post on 22-Jan-2016

83 views

Category:

Documents


0 download

DESCRIPTION

POLLEN AERO ALLERGENS AND THE CLIMATE IN MEDITERRANEAN REGION OF TURKEY AND ALLERGEN SENSITIVITY IN ALLERGIC RHINOCONJUNCTIVITIS AND ALLERGIC ASTHMA PATIENTS. Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

POLLEN AERO ALLERGENS AND THE CLIMATE IN MEDITERRANEAN REGION OF TURKEY AND

ALLERGEN SENSITIVITY IN ALLERGIC RHINOCONJUNCTIVITIS AND ALLERGIC

ASTHMA PATIENTS

Arzu Didem YALCIN.MD

Internal Medicine, Allergy

and Clinical Immunology

Page 2: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

• In this study, we evaluated the profiles of allergic rhino-conjunctivitis and asthma patients annually in Antalya, with aclimate and pollination features typical for a mediterranean coastal city in Turkey

• The prevalences of asthma, allergic rhinitis and allergic eye disease were detected as 8.2%, 10.8% and 7.5% respectively in Antalya, the south coast of Turkey. In this study, evaluated in allergic rhino-conjunctivitis and asthma patients

Page 3: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology
Page 4: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

The total and specific IgE levels were made by fluoroenzyme immunoassay method via use of ImmunoCAP kit. For dermal prick tests Alyostal ST-IR standard allergen extracts were used. 866 of 2862 patients who had allergic rhinoconjunctivitis and asthma were enrolled in the study due to having high total IgE levels in blood conducted at the Allergy- Immunology Unit.  Allergen-spesific subcutaneous immunotherapy was given 626 of 866 patients

Page 5: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

•A questionnaire taking the latest literature data into consideration, were used during the study. These data were oriented to determine

the socio-demographic characteristics including the age, gender, place of living, past

medical history, diseases that they had, beginning and duration of the symptoms,

irritants and allergens that exacerbating the disease and the smoking status.

Page 6: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

Genetic FactorGenetic FactorAtopyAtopy

(Cytokine(CytokineDysregulationDysregulation))

EnvironmentalEnvironmentalFactorFactor

AllergenAllergen

PollutantPollutant

chemicalchemical

Infection…ecInfection…ectt

ASTHMAASTHMA

Developmental ComponentDevelopmental Component

PERSISTENT WHEEZINGPERSISTENT WHEEZING

Page 7: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

RESULTS

Of the 866 patients studied, 66.1 % were females and the largest age groups for the

diagnosis whom had higher than 100 kU/L total IgE levels and allergen-spesific IgE positivity is

the 30-39 ages (23.4 %), as shown in table I. 92.8 % of all patients lived in the city center.

Skin prick test performed mostly on May (17.6 %) 16.3 % of the cases were active smokers.

Among these cases 40.7 % had increased symptoms with cigarette smoke both in active

and passive smoking conditions. There is also a significantly higher SPT positivity rate to trees,

mold and epithelium allergens among the smokers.

Number of

patients

Percentage %

SEX

Male 294 33,9

Female 572 66,1

AGE

i.19 179 20,7

20-29 192 22,2

30-39 203 23,4

40-49 155 17,9

50-59 83 9,6

60+ 54 6,2

Page 8: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

CLINICAL VISIT, MONTH

January 59 6,8

February 92 10,6

March 86 9,9

April 104 12

May 152 17,6

June 127 14,7

July 55 6,4

August 40 4,6

September 48 5,5

October 24 2,8

November 40 4,6

December 39 4,5

Page 9: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology
Page 10: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology
Page 11: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology
Page 12: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

Test x ± SD (mm) Minimum maximum size(mm)

Positive Result

Number of patients Percentage of patients

Positive control 11,15±3,79 1-.24 863 99,6

Negative control 0,17±1,03 2.6

GRASSES MIXTURE 5,86±4,03 1-.30 703 81,2

holcuslanatus 4,14±4,08 3-.23 512 59,1

dactylisglomerata 4,75±4,40 3 – 26 594 68,6

loliumperenne 4,56±4,29 1-.28 568 65,6

phleumpratense 3,46±3,76 3 – 21 452 52,2

poapratensis 3,54±3,92 2 – 24 459 53

festucapratensis 3,15±3,74 2 – 19 416 48

BARLEY MIXTURE 4,09±4,20 2-30 516 59,6

hordeumvulgare 2,78±3,65 3 – 20 366 42,3

triticumsativum 2,61±3,54 2 – 20 351 40,5

secalecereale 2,32±3,63 2 – 22 316 36,5

avenasativa 2,32±3,35 2 – 18 319 36,8

WEED MIXTURE 3,35±3,39 1 – 21 471 54,4

artemissiavulgaris 3,26±3,21 3 – 14 477 55,1

urticadioica 2,45±2,99 2 – 12 372 42,9

plantagolanceolata 2,65±3,15 3 – 18 396 45,7

taraxacumofficianele 2,46±3,33 3 – 20 353 40,8

Page 13: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

EPITHELIUM        

dog 3,30±3,14 2 – 10 486 56,1

cat 2,91±3,26 3 – 15 415 47,9

horse 0,08±0,71 4 – 9 10 1,1

FUNGAL ALLERGENS

       

alternaria 3,38±3,18 2 – 18 496 57,3

aspergillusfumigatus 3,36±3,17 3 – 19 493 56,9

MITES MIX        

D. pteronyssinus 3,88±3,69 3 – 36 532 61,4

D. farinae 3,95±4,54 3 – 45 517 59,7

P. germenica 0,07±0,70 4 – 11 9 1

P. america 0,03±0,39 3 – 8 4 0,5

cockroach 2,73±3,32 1-35 457 52,8

Page 14: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

TREES MIXTURE 3,22±3,46 Mar.21 433 50

alnusglutinosa 2,40±3,19 3 – 18 337 38,9

corylusavellana 2,42±3,50 3 – 44 326 37,6

populusalba 2,52±3,12 3 – 13 366 42,3

salixcaprea 2,69±3,08 2 – 11 397 45,8

betulaverricosa 2,12±2.99 3 – 10 307 35,4

pinussilvestris 1,45±2,68 3 – 10 207 23,9

quereusrobur 2,58±3,03 3 – 10 386 44,6

robininapseudoacacia

0,17±1,03 2 – 10 23 2,6

oleaauropeae 3,57±3,48 3 – 18 491 56,7

Page 15: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

All the SPT results were given in table II. In our study 52.8 % of the cases had sensitivity for cockroaches. In the study group, the SPT positivity rate to cockroaches increased by age. And this increase was statistically different. The detection of cockroaches in the house had no effect on the results of SPT.

Page 16: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

AGECorylusavellana Aspergillus Dpteronyssinus Plantagolanceolata

X±Sd (mm) fumigatus X±Sd (mm) X±Sd (mm)

  X±Sd (mm)    

<40

2,21±3,14 3,59±3,12 4,12±3,78 3,00±3,49

40+

2,82±4,09 2,93±3,23 3,42±3,47 2,19±2,90

Independent-samples t-test

p=0,02 p=0,004 p=0,008 p=0,001

Page 17: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology
Page 18: Arzu Didem YALCIN.MD Internal Medicine, Allergy and Clinical Immunology

Thank youThank you

ARZU DIDEM YALCIN

Prof. Dr. H. Hüseyin Polat, MD:Prof. Dr. H. Hüseyin Polat, MD: Cumhuriyet University, Faculty of Cumhuriyet University, Faculty of Medicine, Department of Public Health, Medicine, Department of Public Health, 58140 Sivas, Turkey58140 Sivas, Turkey

Saime BASARAN, MscSaime BASARAN, Msc

Atıl Bısgın, MD.Atıl Bısgın, MD.

Prof. Dr. Reginald M GORCZYNSKI, Prof. Dr. Reginald M GORCZYNSKI, MD, PhD: MD, PhD: Division of Cellular & Molecular Division of Cellular & Molecular Biology, Toronto Hospital, University Biology, Toronto Hospital, University Health Network, Toronto, ON, Canada.Health Network, Toronto, ON, Canada.

REYHAN, RAHİME, HALE, BÜLENTREYHAN, RAHİME, HALE, BÜLENT